These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32377552)

  • 1. The Inflammatory Bowel Disease Questionnaire in Randomized Controlled Trials of Treatment for Ulcerative Colitis: Systematic Review and Meta-Analysis.
    Yarlas A; Maher S; Bayliss M; Lovley A; Cappelleri JC; Bushmakin AG; DiBonaventura MD
    J Patient Cent Res Rev; 2020; 7(2):189-205. PubMed ID: 32377552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Literature Review: Ability of the IBDQ-32 to Detect Meaningful Change in Ulcerative Colitis Health Indicators.
    Dubinsky M; Rice A; Yarlas A; Hur P; Cappelleri JC; Kulisek N; Fahrny A; Bushmakin A; Biedermann L
    Inflamm Bowel Dis; 2023 Dec; ():. PubMed ID: 38150386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity and reliability of the health-related questionnaire IBDQ-32 in Mexican patients with inflammatory bowel disease.
    Zavala-Solares MR; Salazar-Salas L; Yamamoto-Furusho JK
    Gastroenterol Hepatol; 2021 Dec; 44(10):711-718. PubMed ID: 33872624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the Japanese Inflammatory Bowel Disease Questionnaire in patients after ileal pouch anal anastomosis for ulcerative colitis.
    Watanabe K; Funayama Y; Fukushima K; Shibata C; Takahashi K; Ogawa H; Haneda S; Kudo K; Kohyama A; Sasaki I;
    J Gastroenterol; 2006 Jul; 41(7):662-7. PubMed ID: 16933003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the Persian version of the inflammatory bowel disease questionnaire (IBDQ) in ulcerative colitis patients.
    Maleki I; Taghvaei T; Barzin M; Amin K; Khalilian A
    Caspian J Intern Med; 2015; 6(1):20-4. PubMed ID: 26221492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Spanish translation, adaptation, and validation of the 32-item questionnaire on quality of life for inflammatory bowel disease(IBDQ-32)].
    Masachs M; Casellas F; Malagelada JR
    Rev Esp Enferm Dig; 2007 Sep; 99(9):511-9. PubMed ID: 18052646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the mainland Chinese version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for ulcerative colitis and Crohn's disease.
    Ren WH; Lai M; Chen Y; Irvine EJ; Zhou YX
    Inflamm Bowel Dis; 2007 Jul; 13(7):903-10. PubMed ID: 17309070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tofacitinib in Patients with Ulcerative Colitis: Inflammatory Bowel Disease Questionnaire Items in Phase 3 Randomized Controlled Induction Studies.
    Dubinsky MC; DiBonaventura M; Fan H; Bushmakin AG; Cappelleri JC; Maller E; Thorpe AJ; Salese L; Panés J
    Inflamm Bowel Dis; 2021 Jun; 27(7):983-993. PubMed ID: 32794567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placebo Effect on the Health-related Quality of Life of Inflammatory Bowel Disease Patients: A Systematic Review With Meta-analysis.
    Estevinho MM; Afonso J; Rosa I; Lago P; Trindade E; Correia L; Dias CC; Magro F;
    J Crohns Colitis; 2018 Nov; 12(10):1232-1244. PubMed ID: 30010736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shortened questionnaire on quality of life for inflammatory bowel disease.
    Alcalá MJ; Casellas F; Fontanet G; Prieto L; Malagelada JR
    Inflamm Bowel Dis; 2004 Jul; 10(4):383-91. PubMed ID: 15475746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the inflammatory bowel disease questionnaire in Swedish patients with ulcerative colitis.
    Hjortswang H; Järnerot G; Curman B; Sandberg-Gertzén H; Tysk C; Blomberg B; Almer S; Ström M
    Scand J Gastroenterol; 2001 Jan; 36(1):77-85. PubMed ID: 11218243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review with network meta-analysis: the impact of medical interventions for moderate-to-severe ulcerative colitis on health-related quality of life.
    Paschos P; Katsoula A; Salanti G; Giouleme O; Athanasiadou E; Tsapas A
    Aliment Pharmacol Ther; 2018 Dec; 48(11-12):1174-1185. PubMed ID: 30378141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life in Korean patients with inflammatory bowel diseases: ulcerative colitis, Crohn's disease and intestinal Behçet's disease.
    Kim WH; Cho YS; Yoo HM; Park IS; Park EC; Lim JG
    Int J Colorectal Dis; 1999 Feb; 14(1):52-7. PubMed ID: 10207731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SIBDQ: further validation in ulcerative colitis patients.
    Han SW; Gregory W; Nylander D; Tanner A; Trewby P; Barton R; Welfare M
    Am J Gastroenterol; 2000 Jan; 95(1):145-51. PubMed ID: 10638574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the influence of disease activity on the quality of life of patients with inflammatory bowel disease using a short questionnaire.
    Casellas F; Alcalá MJ; Prieto L; Miró JR; Malagelada JR
    Am J Gastroenterol; 2004 Mar; 99(3):457-61. PubMed ID: 15056085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quality of life assessment in Inflammatory Bowel Disease (IBD): German version of the Inflammatory Bowel Disease Questionnaire (IBDQ-D; disease-specific instrument for quality of life assessment) -- first application and comparison with international investigations].
    Janke KH; Steder-Neukamm U; Bauer M; Raible A; Meisner C; Hoffmann JC; Gregor M; Klump B; Häuser W
    Gesundheitswesen; 2005; 67(8-9):656-64. PubMed ID: 16217720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Wang Y; Parker CE; Bhanji T; Feagan BG; MacDonald JK
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD000543. PubMed ID: 27101467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of golimumab on health-related quality of life, other patient-reported outcomes and healthcare resource utilization in patients with moderate-to-severe ulcerative colitis: a real-world multicenter, noninterventional, observational study in Greece.
    Gatopoulou A; Christodoulou DK; Katsanos KH; Bakos D; Mouzas I; Tzouvala M; Theodoropoulou A; Paspatis G; Theocharis G; Thomopoulos K; Giouleme O; Kourikou A; Manolakopoulos S; Zampeli E; Michopoulos S; Karatzas P; Katsaros M; Moschovis D; Orfanoudaki E; Livieratos A; Petrikkou E; Mantzaris GJ
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e615-e624. PubMed ID: 34034278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does self-administration of a quality of life index for inflammatory bowel disease change the results?
    Irvine EJ; Feagan BG; Wong CJ
    J Clin Epidemiol; 1996 Oct; 49(10):1177-85. PubMed ID: 8826999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.